Introduction
============

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States.[@b1-copd-7-211] Although it has been diagnosed in more than 10 million people, as many as 24 million may have airflow limitation consistent with COPD.[@b1-copd-7-211] Historically, measures of pulmonary function, such as the forced expiratory volume in 1 second test, have been the standard markers for physiological change in COPD, but have only been weakly associated with dyspnea (shortness of breath) and other symptoms.[@b2-copd-7-211] Thus, patient-reported outcomes such as health-related quality of life (HRQoL) and work productivity have become important measures in COPD therapy.[@b3-copd-7-211]

In an effort to improve COPD management, much research has focused on the complex interrelationships between the HRQoL of COPD patients and the determining factors thereof. Age, gender, disease severity, smoking, socioeconomic status, and psychological factors have been studied in detail, even if little agreement about their effects on HRQoL has been made.[@b4-copd-7-211]--[@b8-copd-7-211] However, few studies have examined the impact of COPD among the US workforce. Previous studies have shown that the diagnosis of COPD was associated with a reduction in workforce participation and disability.[@b9-copd-7-211],[@b10-copd-7-211] Among those patients who are able to maintain their place in the workforce, however, the extent of COPD burden is unclear. While some studies have investigated the impact of the disease on absenteeism (time missed from work), research on the subtle effects of presenteeism (lost productivity while at work) have largely been neglected.[@b11-copd-7-211]

Although resource use has been documented among younger employees diagnosed with COPD,[@b12-copd-7-211] studies typically did not assess self-reported health care utilization. An approach from the employee perspective could complement this literature, especially when comparing resource use of COPD workers to controls. The aim of this study is to assess the impact of COPD on HRQoL, work productivity, and resource use among employed adults.

Methods
=======

Sample
------

Data were obtained from 75,000 respondents who completed the 2009 US National Health and Wellness Survey (NHWS), an annual, cross-sectional study of patients aged 18 years or older. The self-administered, Internet-based questionnaire was given to a sample population identified through a web-based consumer panel whose members were recruited through opt-in emails, co-registration with panel partners, e-newsletter campaigns, online banner placements, and both internal and external affiliate networks. All panelists explicitly agreed to become panel members, registered through unique email addresses, and completed in-depth demographic registration profiles. A stratified random sampling procedure was implemented, using strata based on gender, age, and race/ethnicity, in order for the sample to be representative of the demographic composition of the general population. The study was approved by the Essex Institutional Review Board.

Of the 501,239 who were contacted, 92,759 responded (an 18.5% response rate). Of those who responded, 75,000 gave their informed consent, met the inclusion criteria (aged 18 years or over), and completed the survey instrument. The demographic composition of the US NHWS sample is comparable to that of the US adult population as assessed by the Current Population Survey of the US Census Bureau and prevalence estimates of various conditions from NHWS are consistent with other well-established sources such as the National Health Interview Survey.[@b13-copd-7-211] In the current study, data were analyzed only for workers (full-time employed, part-time employed, or self-employed) aged 40--64 years (n = 20,024).

Measures
--------

### COPD diagnosis

All NHWS respondents were asked a series of questions regarding conditions they might have previously experienced. Those who self-reported experiencing chronic bronchitis, emphysema, or COPD in the past were then asked whether their condition had been diagnosed by a physician. Those who self-reported a diagnosis of COPD, who were 40--64 years of age and employed (full-time, part-time, or self-employed) were compared with those not diagnosed with COPD, who were 40--64 years of age and employed (see [Figure 1](#f1-copd-7-211){ref-type="fig"}). No other information (clinical or otherwise) was used to define the groups.

### Demographics

Data on each worker's age, gender, race/ethnicity (non-Hispanic white, non-Hispanic black/African-American, Hispanic, or other), highest educational level attained ( college degree or more vs less than college degree), previous year's household income (\<\$25,000, \$25,000 to \<\$50,000, \$50,000 to \<\$75,000, \$75,000 or more, or decline to answer), health insurance (yes vs no), health insurance with prescription coverage (yes vs no), and type of employment (full-time, part-time, or self-employed) were assessed.

### Health history

Workers also provided data on their body mass index (BMI) level (categorized by reported weight and height: underweight (\<18.5), normal (18.5--24.9), overweight (25.0--29.9), obese (≥30), and missing BMI information, smoking status (current smoker, former smoker, or never smoker), exercise behavior (exercised in the past month vs not exercised in the past month), and alcohol use (current drinker vs non-drinker). Self-reported diagnosis of asthma and the estimation of the Charlson comorbidity index (CCI) were also measured. The CCI captures the extent of comorbid burden and is calculated by weighting the presence of the following conditions and summing the result: HIV/AIDS, metastatic tumor, lymphoma, leukemia, any tumor, moderate/severe renal disease, hemiplegia, diabetes, mild liver disease, ulcer disease, connective tissue disease, chronic pulmonary disease, dementia, cerebrovascular disease, peripheral vascular disease, myocardial infarction, and congestive heart failure (note that the adjusted CCI does not include diabetes with end organ damage and moderate/severe liver disease which appears in the original CCI; otherwise the calculations are identical to the original algorithm).

### HRQoL

HRQoL was assessed using the SF-12v2, a generic HRQoL instrument which includes twelve items.[@b14-copd-7-211] The SF-12v2 instrument has an extensive body of literature to support its validity and reliability.[@b14-copd-7-211] The mental component summary and physical component summary scores were used in the current study. These summary scores are normed to the US population and have a mean of 50 and a standard deviation of 10. Health state utilities, preference-based single index measures of health, were also calculated from the SF-12 items, and included as the SF-6D. Utility scores vary from 0 (death) to 1 (full health).

### Work productivity and activity impairment

Work productivity and impairment were assessed using the Work Productivity and Activity Impairment Questionnaire: General Health.[@b15-copd-7-211] Derived from the questionnaire were four metrics: absenteeism (the percentage of work time missed due to health in the past 7 days), presenteeism (the percentage of impairment while at work due to health in the past 7 days), overall work loss (the total percentage of missed time due to absenteeism and presenteeism in the past 7 days), and activity impairment (the percentage of impairment suffered during daily activities in the past 7 days). Each metric varies from 0% to 100% with higher scores indicating greater impairment.

Absenteeism is calculated by dividing the number of work hours a worker missed in the past week because of their health by the total number of hours they could have worked (the number of hours they did work plus the number of hours they missed because of their health), then converting this proportion into a percentage. Presenteeism was measured by a worker's reported level of impairment experienced while at work in the past 7 days (from 0 to 10), which was then multiplied by ten to create a percentage. Overall work impairment was measured by combining absenteeism and presenteeism. Activity impairment was measured by a worker's response to their level of impairment experienced in daily activities in the past 7 days (from 0 to 10), which was then multiplied by ten to create a percentage.

The Work Productivity and Activity Impairment Questionnaire: General Health has been found to have adequate reliability and validity.[@b15-copd-7-211] The scale has also been used in a variety of disease areas including asthma[@b16-copd-7-211] and has been used to measure differences in those with and without particular diseases to assess burden of illness.[@b13-copd-7-211],[@b17-copd-7-211],[@b18-copd-7-211]

### Health care resource use

Health care utilization was defined by traditional health care providers such as general practitioners and internists ("which of the following traditional health care providers have you seen in the past 6 months?"). Additionally, the number of traditional health care visits, the number of emergency room (ER) visits ("how many times have you been to the ER for your own medical condition in the past 6 months?"), and the number of times hospitalized in the past 6 months ("how many times have you been hospitalized for your own medical condition in the past 6 months?") were included in the analyses.

Analyses
--------

Univariate analyses were conducted on all workers in order to fully describe the sample demographically. Weights (based on 2008 March Current Population Survey) were then applied to the sample to project to the US population. Using the chi- square and *t*-tests for categorical and continuous variables, respectively, and Wilcoxon--Mann--Whitney tests for continuous non-normal variables differences between those diagnosed with COPD, employed, aged 40--64 years and those not diagnosed with COPD, employed, aged 40--64 years were examined on demographic and health history variables.

Multivariable regression analyses were performed to determine whether the COPD group differed from the control group on HRQoL, work productivity, and resource use after adjusting for demographic (reference categories: male, full-time employed, white, single, college educated, income of less than \$25,000, no health insurance) and health history variables (reference categories: not diagnosed with asthma, normal weight, never smoked). Our statistical approach varied depending upon the nature of the dependent variable. Multiple regressions were used for HRQoL variables since the SF-12v2 is normed, and generalized linear models (specifying a negative binomial distribution and a log-link function) were used for work productivity and resource utilization, to adjust for non-normality in the Work Productivity and Activity Impairment Questionnaire: General Health scores and resource use variables. The estimates based on the generalized linear models (work productivity and resource utilization) represent changes in adjusted log values in the given outcome, rather than adjusted values in the outcome, itself. Logistic regressions were used to predict the presence or absence of traditional and non-traditional health care provider visits. All analyses were conducted using SAS (v 9.1; SAS Institute Inc, Cary, NC) and a two-tailed threshold of *P* \< 0.05 was specified to determine statistical significance.

Results
=======

Univariate analyses
-------------------

A total of 20,024 workers were employed and aged 40--64 years. Of those, 1112 were diagnosed with COPD and 18,912 were not diagnosed with COPD. Among those employed, most were male (53.4%), non-Hispanic white (70.3%), married or living with a partner (65.7%), and had received a college education (81.3%). Most workers were employed full-time (70.3%).

Unadjusted comparisons
----------------------

Workers with COPD were significantly less likely to be male (45.54% vs 53.89%, *P* \< 0.0001), non-Hispanic black/African-American (8.75% vs 11.57%, *P* = 0.0012), Hispanic (8.52% vs 12.24%, *P* = 0.0008), full-time employed (64.65% vs 70.60%, *P* \< 0.0001), of normal weight (21.05% vs 25.59%, *P* = 0.0005), overweight (30.10% vs 35.91%, *P* = 0.0004), to have missing BMI information (1.21% vs 1.95%, *P* = 0.0458), and to have a household income of \$75,000 or more per year (26.59% vs 34.42%, *P* \< 0.0001).

Workers with COPD were significantly more likely to be non-Hispanic white (76.45% vs 69.96%, *P* \< 0.0001) or other race/ethnicity (5.04% vs 2.62%, *P* = 0.0103), part-time employed (16.13% vs 13.13%, *P* = 0.0091), self-employed (19.22% vs 16.27%, *P* = 0.0174), diagnosed with asthma (28.00% vs 6.23%, *P* \< 0.0001), obese (46.01% vs 36.18%, *P* \< 0.0001), have a household income of less than \$25,000 per year (13.55% vs 10.00%, *P* = 0.001), and have a household income of \$25,000 to \$49,999 per year (33.20% vs 27.16%, *P* \< 0.0001). COPD workers reported significantly worse health outcomes than non-COPD workers as captured by HRQoL, work productivity, and health care resource use (see [Table 1](#t1-copd-7-211){ref-type="table"}).

Multivariable analyses with adjustments
---------------------------------------

After adjusting for demographic and health history variables, a number of outcome measures were significantly associated with COPD diagnosis. Workers with COPD had significantly lower levels of mental component summary (adjusted means: COPD = 46.76 vs control = 48.51, *P* \< 0.0001), physical component summary (adjusted means: COPD = 45.64 vs control = 49.23, *P* \< 0.0001), and health utility scores (adjusted means: COPD = 0.71 vs control = 0.75, *P* \< 0.0001) (see [Figure 2](#f2-copd-7-211){ref-type="fig"}).

Although there were no significant differences between the groups in regard to absenteeism (adjusted means: COPD = 3.60% vs control = 3.42%, *P* = 0.7180), workers with COPD reported significantly higher levels of presenteeism (adjusted means: COPD = 19.28% vs control = 14.59%, *P* \< 0.0001; see [Figure 3](#f3-copd-7-211){ref-type="fig"}). The composite overall work loss metric was also significantly different between the cohorts (adjusted means: COPD = 20.93% vs control = 16.59%). Activity impairment, or lost productivity outside of work, was also significantly higher among those who reported a COPD diagnosis (adjusted means: COPD = 23.95% vs control = 18.23%, *P* \< 0.0001).

COPD workers reported a significantly higher number of ER visits in the past 6 months (adjusted means: COPD = 0.22 vs control = 0.12, *P* \< 0.0001), hospitalizations (adjusted means: COPD = 0.11 vs control = 0.06, *P* \< 0.0001) in the past 6 months (see [Figure 4](#f4-copd-7-211){ref-type="fig"}), odds of visiting a traditional health care provider (odds ratio = 0.69, *P* = 0.0008), and odds of visiting a non-traditional health care provider (b = 1.167, *P* = 0.0401). However, no significant differences were found in the number of traditional health care provider visits (adjusted means: COPD = 3.33 vs control = 3.06).

Discussion
==========

Although previous studies have examined the impact of COPD on patient-reported outcomes, few studies have focused exclusively on the workforce. Further, prior research has often grouped older and younger workers together,[@b4-copd-7-211] so that limiting the analyses to those aged 40--64 years helps homogenize the sample and isolates those in their peak earning years. This focus is also helpful in that most HRQoL studies have ignored those under the age of 65 years with COPD.[@b4-copd-7-211]--[@b7-copd-7-211],[@b19-copd-7-211],[@b20-copd-7-211]

The results of the current study suggest that workers diagnosed with COPD have significantly lower levels of HRQoL, even after controlling for health history and comorbidities. It is important to note that previous studies have often compared COPD workers to population norms (mean = 50, standard deviation = 10), without direct comparisons with control cohorts.[@b5-copd-7-211],[@b6-copd-7-211] Using such a direct comparison further emphasizes the impact that COPD can have on humanistic outcomes.

Previous studies have found COPD to be associated with reductions in workforce participation[@b9-copd-7-211],[@b21-copd-7-211] and increases in absenteeism.[@b11-copd-7-211] Although a trend toward greater absenteeism was observed here, it was not significant. However, significant differences between the COPD group and the control group were observed on presenteeism, a finding not previously reported. This result is important to emphasize because the effects of COPD may go unnoticed by employers who may focus on work absences rather than lost productivity while at work. Additionally, overall work impairment and activity impairment were also significantly higher among those diagnosed with COPD.

Lastly, health care resource utilization was significantly associated with COPD diagnosis. After accounting for demographic and health history variables, COPD workers were more likely to visit a traditional and non-traditional health care provider, but COPD workers did not report a higher number of traditional provider visits. COPD workers did, however, report significantly more ER visits and hospitalizations relative to controls. It is possible that the lack of additional provider visits may account for some of the humanistic and productivity loss detriments. Perhaps a lack of active management was a reason for poor outcomes and may explain higher rates of ER visits and hospitalizations. Future research is clearly necessary to examine these hypotheses.

Limitations
-----------

Because the NHWS is a cross-sectional survey, all relationships can only be expressed as associations and not causal relationships. Further research employing prospective and longitudinal designs may be useful in corroborating the burden of COPD as observed here, particularly as it relates to resource use. It is also important to note, though every attempt was made to rule out alternative explanations, that unmeasured variables may explain the relationships between group membership and health outcomes. Because of the self-reported nature, recall bias may have introduced additional error into the observed associations. Some patients may have incorrectly reported a COPD diagnosis when they do not have COPD and some patients may have failed to report a COPD diagnosis when they have COPD. Finally, although the NHWS is demographically representative of the US population because of the random stratified sampling framework, the final sample may differ in meaningful ways other than demographics, which could affect the size and direction of the relationships observed here. In other words, those who chose to respond to the survey may differ from those who chose not to respond (eg, health status, health care attitudes, etc) and these factors could artificially inflate or deflate the differences between groups.

Conclusion
==========

Workers diagnosed with COPD reported significantly lower levels of HRQoL and higher levels of presenteeism, overall work impairment, activity impairment, ER visits, and hospitalizations. These effects remained even after adjusting for differences between the COPD group and control group in terms of comorbidities and other health history variables. Though absenteeism rates were similar between the two groups, employers should be aware that productivity losses were significantly higher among COPD workers as were costly ER visits and hospitalizations. Effective programs and policies may be necessary to better manage COPD workers in the workforce.
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![Inclusion and exclusion flow chart.\
**Note:** ^a^Eligible responders included those who provided informed consent, were aged 18 years and over, and completed the survey instrument.\
**Abbreviations:** NHWS, National Health and Wellness Survey; COPD, chronic obstructive pulmonary disease.](copd-7-211f1){#f1-copd-7-211}

![Mean levels of quality of life components after adjusting for patient demographic and patient characteristics (comparing workers with COPD versus those without).\
**Note:** Differences in MCS and PCS were found to be statistically significant (*P* \< 0.0001).\
**Abbreviations:** COPD, chronic obstructive pulmonary disease; MCS, mental component summary score; PCS, physical component summary score.](copd-7-211f2){#f2-copd-7-211}

![Mean levels of work productivity and activity impairment after adjusting for demographics and patient characteristics (comparing workers with COPD versus those without).\
**Note:** Differences in presenteeism, overall work impairment, and activity impairment were found to be statistically significant (*P* \< 0.0001).\
**Abbreviation:** COPD, chronic obstructive pulmonary disease.](copd-7-211f3){#f3-copd-7-211}

![Mean levels of resource use after adjusting for demographics and patient characteristics (comparing workers with COPD versus those without).\
**Note:** Differences in ER visits, hospitalizations, and provider visits were found to be statistically significant (*P* \< 0.0001).\
**Abbreviations:** COPD, chronic obstructive pulmonary disease; ER, emergency room.](copd-7-211f4){#f4-copd-7-211}

###### 

Bivariate comparison of employed 40--64 year old patients diagnosed with COPD versus employed 40--64 year old patients not diagnosed with COPD

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                COPD patients (40--64 years old)\   Controls (40--64 years old)\   *P* value                                                                     
                                                n = 1112                            n = 18,912                                                                                                   
  --------------------------------------------- ----------------------------------- ------------------------------ ----------- ------------------ ------- ---------- -------- ------------------ ----------
  Male                                          533                                 1511835                        45.45%      (42.47%--48.43%)   10435   30704754   53.89%   (53.16%--54.62%)   \<0.0001

  Ethnicity                                                                                                                                                                                      

   White, non-Hispanic                          877                                 2542657                        76.45%      (73.75%--79.15%)   13881   39863805   69.96%   (69.25%--70.67%)   \<0.0001

   Black, non-Hispanic                          103                                 290893                         8.75%       (7.1%--10.4%)      2338    6589930    11.57%   (11.12%--12.02%)   0.0012

   Hispanic                                     58                                  283546                         8.52%       (6.4%--10.64%)     1430    6972640    12.24%   (11.65%--12.83%)   0.0008

   Other                                        6                                   17740                          3.16%       (0.57%--5.75%)     65      352182     6.32%    (4.11%--8.53%)     0.0741

  Married/living with partner                   697                                 2061956                        61.99%      (59.07%--64.91%)   12457   37571023   65.94%   (65.25%--66.63%)   0.0103

  College educated                              896                                 2674020                        80.40%      (78.03%--82.77%)   15460   46369859   81.38%   (80.81%--81.95%)   0.4306

  Income                                                                                                                                                                                         

   \<\$25 K                                     149                                 450813                         13.55%      (11.49%--15.61%)   1869    5695620    10.00%   (9.57%--10.43%)    0.001

   \$25 K--50 K                                 371                                 1104188                        33.20%      (30.38%--36.02%)   5111    15477375   27.16%   (26.51%--27.81%)   \<0.0001

   \$50 K--75 K                                 263                                 771083                         23.18%      (20.69%--25.67%)   4560    13726238   24.09%   (23.46%--24.72%)   0.4903

   \>\$75 K                                     293                                 884320                         26.59%      (23.92%--29.26%)   6549    19612824   34.42%   (33.73%--35.11%)   \<0.0001

   Decline                                      36                                  115673                         3.48%       (2.32%--4.64%)     823     2467116    4.33%    (4.04%--4.62%)     0.1592

  Employment                                                                                                                                                                                     

   Full-time                                    719                                 2150233                        64.65%      (61.79%--67.51%)   13397   40225093   70.60%   (69.93%--71.27%)   \<0.0001

   Part-time                                    182                                 536449                         16.13%      (13.93%--18.33%)   2501    7484109    13.13%   (12.64%--13.62%)   0.0091

   Self-employed                                211                                 639395                         19.22%      (16.85%--21.59%)   3014    9269970    16.27%   (15.72%--16.82%)   0.0174

  Health insurance                              907                                 2720505                        81.79%      (79.52%--84.06%)   15736   47332681   83.07%   (82.52%--83.62%)   0.2861

  Health insurance with Rx coverage             855                                 2557230                        76.88%      (74.37%--79.39%)   14800   44530832   78.15%   (77.54%--78.76%)   0.3367

  Body mass index                                                                                                                                                                                

   Underweight                                  31                                  94486                          2.84%       (1.84%--3.84%)     546     1660531    2.91%    (2.66%--3.16%)     0.8885

   Normal                                       233                                 700061                         21.05%      (18.6%--23.5%)     4793    14582145   25.59%   (24.94%--26.24%)   0.0005

   Overweight                                   329                                 1001119                        30.10%      (27.32%--32.88%)   6709    20119789   35.31%   (34.6%--36.02%)    0.0004

   Obese                                        519                                 1530411                        46.01%      (43.03%--48.99%)   6864    20616708   36.18%   (35.47%--36.89%)   \<0.0001

   Decline                                      12                                  40342                          1.21%       (0.52%--1.9%)      360     1108841    1.95%    (1.75%--2.15%)     0.0458

  Diagnosed with asthma                         309                                 931424                         28.00%      (25.3%--30.7%)     1145    3548491    6.23%    (5.88%--6.58%)     \<0.0001

  Smoking habits                                                                                                                                                                                 

   Never                                        46                                  131708                         23.49%      (13.32%--33.66%)   1179    2256193    40.49%   (37.88%--43.1%)    0.0005

   Former                                       175                                 313600                         55.93%      (46.78%--65.08%)   1523    2743564    49.23%   (46.68%--51.78%)   0.1536

   Current                                      76                                  115349                         20.57%      (14.93%--26.21%)   359     572895     10.28%   (9.01%--11.55%)    0.0002

  Resource use (visited traditional provider)   970                                 2898723                        87.15%      (85.13%--89.17%)   14508   43652425   76.61%   (75.98%--77.24%)   \<0.0001

  Resource use (visited ER)                     225                                 681566                         20.49%      (18.06%--22.92%)   1691    5157451    9.05%    (8.62%--9.48%)     \<0.0001

  Resource use (visited hospital)               144                                 437769                         13.16%      (11.1%--15.22%)    948     2877141    5.05%    (4.74%--5.36%)     \<0.0001
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                          COPD patients (40--64 years old)\   Controls (40--64 years old)\   *P* value                                                                    
                                          n = 1112                            n = 18,912                                                                                                  
  --------------------------------------- ----------------------------------- ------------------------------ ----------- ------------------ -------- -------- -------- ------------------ ----------
  Charlson index (mean, SD)               1.74                                1.74                           1.21        (1.66--1.82)       0.33     0.33     0.85     (0.31--0.35)       \<0.0001

  SF-12                                                                                                                                                                                   

   MCS (mean, SD)                         44.54                               44.53                          11.37       (43.86--45.2)      48.83    48.75    10.17    (48.61--48.89)     \<0.0001

   PCS (mean, SD)                         41.62                               41.67                          10.9        (41.02--42.32)     49.71    49.7     8.89     (49.58--49.82)     \<0.0001

   Health utilities (mean, SD)            0.67                                0.67                           0.13        (0.67--0.67)       0.76     0.76     0.14     (0.76--0.76)       \<0.0001

  Work productivity                                                                                                                                                                       

   Absenteeism % (mean, SD)               7.85%                               7.86%                          19.11%      (6.72%--9%)        3.66%    3.73%    14.54%   (3.51%--3.95%)     \<0.0001

   Absenteeism hours (mean, SD)           2.57                                2.57                           6.6         (2.18--2.96)       1.32     1.34     5.71     (1.26--1.42)       \<0.0001

   Presenteeism % (mean, SD)              30.77%                              30.75%                         28.39%      (29.04%--32.46%)   14.72%   14.90%   23.05%   (14.57%--15.23%)   \<0.0001

   Presenteeism hours (mean, SD)          9.73                                9.76                           9.94        (9.15--10.37)      4.95     4.97     8.26     (4.85--5.09)       \<0.0001

   Overall work impairment % (mean, SD)   34.05%                              34.06%                         31.28%      (32.2%--35.92%)    16.77%   16.95%   26.00%   (16.58%--17.32%)   \<0.0001

   Activity impairment % (mean, SD)       37.32%                              37.33%                         29.22%      (35.61%--39.05%)   18.34%   18.48%   25.35%   (18.13%--18.83%)   \<0.0001

  Number of provider visits (mean, SD)    0.42                                0.43                           1.73        (0.33--0.53)       0.13     0.14     0.79     (0.12--0.16)       \<0.0001

  Number of ER visits (mean, SD)          0.21                                0.22                           1.31        (0.14--0.3)        0.07     0.07     0.44     (0.07--0.07)       \<0.0001

  Number of hospitalizations (mean, SD)   5.75                                5.8                            8.14        (5.33--6.27)       3.22     3.21     4.86     (3.13--3.29)       \<0.0001
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** COPD, chronic obstructive pulmonary disease; SD, standard deviation; M, mean; MCS, mental component summary score; CI, confidence interval; ER, emergency room; PCS, physical component summary score; Rx, prescription covered.
